Collectively, our findings demonstrate that AZGP1 is specifically expressed in a soluble form by CCA cells treated with 5-FU, which may influence the cell death through the activation of the PD-L1-dependent AKT signaling pathway. The gene discussed is AKT1; the disease is cholangiocarcinoma.